LFCR Prakiraan pendapatan perusahaan Lifecore Biomedical Inc.

Logo perusahaan publik Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical (LFCR) planned sales levels demonstrate resilience driven by strict FDA oversight and patent protection. Lifecore Biomedical (LFCR) revenues are based on the production of hyaluronic acid and sterile fill-finish services. Predictive monitoring of raw material inventories ensures operational stability. The current level of 0.00 captures fresh values, allowing for an objective assessment of the asset's fundamental value during periods of market volatility.

LFCR - Dodolan mangsa ngarep perusahaan Lifecore Biomedical ing rentang 28.04.2023 - 13.11.2026

Ringkesan rincian data analitis Lifecore (LFCR)

- nilai saham lan prakiraan konsensus rega:
Bagan rega Lifecore Biomedical|LFCR - Target median analis
- data kapitalisasi pasar:
Nilai pasar Lifecore Biomedical Inc.|LFCR - Nilai Total Perusahaan
- data ekuitas miturut neraca:
Nilai Buku saben Saham Lifecore Biomedical|LFCR - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku lifecore.com|LFCR - Nilai Total Aset Perusahaan
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Lifecore Biomedical|LFCR - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Lifecore Biomedical|LFCR - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Lifecore Biomedical Inc.|LFCR - Utang jangka dawa|Utang jangka cendhak perusahaan Lifecore Biomedical|Rasio cepet lifecore.com
- statistik bathi lan rasio pasar:
LFCR - Penghasilan resik perusahaan|Bathi mangsa ngarep Lifecore Biomedical|LFCR - Nilai perusahaan marang bathi resik|Pangali Forward P/E Lifecore Biomedical|LFCR - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA Lifecore Biomedical Inc.|LFCR - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Lifecore Biomedical|LFCR - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan lifecore.com|LFCR - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Lifecore Biomedical
- data pendapatan lan penerimaan dodolan:
LFCR - Total pendapatan perusahaan|Prakiraan volume dodolan Lifecore Biomedical|LFCR - Rasio kapitalisasi marang pendapatan|Multiplikator Forward P/S Lifecore Biomedical Inc.
Analisis fundamental perusahaan:LFCR Lifecore Biomedical, Inc.
Produk merek Lifecore

This indicator synthesizes the market expectations of traders, converting current quotes into a leading forecast of future revenue to assess the fundamental value of the business. For Lifecore Biomedical (LFCR), whose model is based on stable long-term biopharmaceutical contracts, analyzing the sales volume forecast allows for the timely identification of structural shifts in demand while ignoring short-term market noise.

Pesaing Lifecore Biomedical (LFCR)

Prakiraan pendapatan perusahaan IQVIA Holdings Inc. (IQV)|Dodolan mangsa ngarep perusahaan labcorp.com|Prakiraan pendapatan perusahaan Medpace MEDP|ICON Plc - Prakiraan pendapatan perusahaan|Charles River Lab - Prakiraan volume dodolan|Dodolan mangsa ngarep perusahaan Evotec Group EVO|FTRE: Prakiraan volume dodolan|Pendapatan sing dikarepake perusahaan OABI (omniab.com)|NOTV (Inotiv) - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Avid Bioservices Inc. CDMO|Prakiraan volume dodolan CTLT|Volume dodolan mangsa ngarep perusahaan Scorpius Holdings, Inc SCPX